China Universal Asset Management Company’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$37.2K	Buy	12,860 +61	+0.5%	+$176	﹤0.01%	435
2025 Q1	$27.5K	Sell	12,799 -730	-5%	-$1.57K	﹤0.01%	448
2024 Q4	$52.4K	Buy	+13,529	New	+$52.4K	﹤0.01%	449
2022 Q4	–	Sell	-165	Closed	-$1K	–	429
2022 Q3	$1K	Buy	+165	New	+$1K	﹤0.01%	400